Fatima Cardoso
Overview
Explore the profile of Fatima Cardoso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
250
Citations
12678
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cardone A, Bell D, Biurrun C, Cognetti F, Cardoso F, Piris A, et al.
Breast
. 2025 Mar;
81:104436.
PMID: 40058335
Purpose: Genomic testing, involving expression profiling of tumour tissue, is a powerful tool for determining appropriate treatments for certain cancer patients. This study aimed to evaluate awareness of genomic testing...
2.
3.
Bjelic-Radisic V, Cardoso F, Weis J, Pogoda K, Arraras J, Greimel E, et al.
Breast
. 2025 Feb;
80:103890.
PMID: 39947087
Background: The EORTC QLQ-BR23, published in 1996, was one of the first disease-specific questionnaires to assess health-related quality of life (HRQoL) in patients with breast cancer (BC). In the last...
4.
Pareja F, Bhargava R, Borges V, Brogi E, Canas Marques R, Cardoso F, et al.
NPJ Breast Cancer
. 2025 Jan;
11(1):6.
PMID: 39856067
Special histologic subtypes of breast cancer (BC) exhibit unique phenotypes and molecular profiles with diagnostic and therapeutic implications, often differing in behavior and clinical trajectory from common BC forms. Novel...
5.
Cardoso F, OShaughnessy J, Liu Z, McArthur H, Schmid P, Cortes J, et al.
Nat Med
. 2025 Jan;
31(2):442-448.
PMID: 39838117
Addition of pembrolizumab to neoadjuvant chemotherapy followed by adjuvant pembrolizumab improved outcomes in patients with high-risk, early-stage, triple-negative breast cancer. However, whether the addition of neoadjuvant pembrolizumab to chemotherapy would...
6.
Vasconcelos de Matos L, Borges M, Oliveira A, Bulhosa C, Miguel L, Fidalgo de Freitas T, et al.
Breast
. 2025 Jan;
79:103867.
PMID: 39753059
This study aimed to characterize the employment status and work-related conditions of patients with advanced breast cancer (ABC) in Portugal and quantify the productivity costs of premature abandonment of the...
7.
Vaz S, Groheux D, van Nijnatten T, Antunovic L, Cardoso F, Mottaghy F, et al.
Eur J Nucl Med Mol Imaging
. 2024 Dec;
52(3):801-805.
PMID: 39706898
No abstract available.
8.
Resende C, Abreu M, Presa Ramos J, Carda J, Costa L, Cardoso F, et al.
Cureus
. 2024 Dec;
16(11):e73720.
PMID: 39677142
Introduction Over the past decades, clinical research has evolved significantly, driven by advances in regulatory frameworks, technological innovations, and methodological approaches. In Portugal, while there has been progress - such...
9.
Cardoso F, Hirshfield K, Kraynyak K, Tryfonidis K, Bardia A
NPJ Breast Cancer
. 2024 Dec;
10(1):104.
PMID: 39643613
Additional therapies are needed to improve outcomes in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer. Research on the potential role of immunotherapy, particularly programmed cell death...
10.
Morgan E, ONeill C, Shah R, Langselius O, Su Y, Frick C, et al.
Breast Cancer Res
. 2024 Nov;
26(1):171.
PMID: 39605105
Background: To assess proportions of metastatic recurrence in women initially diagnosed with non-metastatic breast cancer by stage at diagnosis, breast cancer subtype, calendar period and age. Methods: A systematic search...